29 reports

Abstract: - Global Neglected Tropical Diseases Diagnosis Market to Reach $7.9 Billion by 2027 - Amid the COVID-19 crisis, the global market for Neglected Tropical Diseases Diagnosis estimated at US$6 Billion in the year 2020, is projected to reach a revised size of US$7.9 Billion by 2027, growing at aCAGR of 4% over...

  • Tropical Disease
  • Diagnostics
  • World
  • China
  • United States

International Stem Cell United States World Research And Development Pharmaceutical Healthcare Drug Delivery Regenerative Medicine Tropical Disease

  • Biotechnology
  • Pharmaceutical
  • Infectious Disease
  • North America
  • Freezer Sales
  • Energy Consumption

Point of Care POC Infectious Disease Diagnostics Market Size, Outlook and Growth Opportunities, 2019- 2025 Global POC Infectious Disease Diagnostics Market Size, Outlook and Growth Opportunities to 2025: By Technology( Lateral Flow, Agglutination Assays, Flow Through, Solid Phase, and Others), By Application( Tropical...

  • Infectious Disease
  • Managed Care
  • Diagnostics
  • World
  • APAC
  • Asia
  • Europe
  • North America
  • Middle East
  • Africa
  • Latin America
  • Health Expenditure

The TT##CL consortium announced that it has been awarded EUR ## million to develop an oral treatment, D##, against one of the most neglected tropical diseases, cutaneous leishmaniasis.

  • Autoimmune Disease
  • United States
  • Prescription Drug Sales
  • Medical Technology Density

Vault Pharma is in preclinical development stages for a therapeutic vaccine for chlamydiarelated pelvic inflammatory disease, a major cause of pain and infertility in young women; and trachoma, a neglected tropical disease that is the leading cause for blindness in developing countries.

  • Cancer
  • World
  • China
  • Beijing Municipality
  • Drug Approval
  • Mortality Rate

The company's products are used for the treatment of tropical infectious diseases such as enterovirus ## and coxsackievirus A##, which spreads into lymphatic system and bloodstream and causes systemic infections involving several organs.

  • Mouth Disease
  • Drug Development
  • World
  • China

Tropical Diseases

  • Infectious Disease
  • Diagnostics
  • World
  • United States
  • Europe
  • APAC
  • North America
  • Health Expenditure
  • Drug Approval

Oblita Therapeutics announced that D## is eligible to receive a FDA Priority Review Voucher upon its approval for the treatment on Leishmaniasis or another Neglected Tropical Disease.

  • Autoimmune Disease
  • Infectious Disease
  • Drug Development
  • United States
  • Medical Technology Density
  • Rural Population

The company‟s products are used for the treatment of tropical infectious diseases such as enterovirus ## and coxsackievirus A##, which spreads into lymphatic system and bloodstream and causes systemic infections involving several organs.

  • Mouth Disease
  • World
  • China
  • Pharmaceutical Exports
  • Drug Approval

Biosy nex's products are used in the therapeutic areas such as infectious diseases, emergency markers, obstetric, parasitology and virology, tropical diseases, and autoimmune diseases, among others.

  • Infectious Disease
  • Clinical Trial
  • World
  • India
  • Zhejiang
  • Pneumonia Prevalence
  • Direct Sales

In June 2013, Aix-Marseille Universite filed a patent EP##.## titled "A new chemical family to treat tropical diseases induced by Dengue virus and other Flaviviruses".

  • Infectious Disease
  • Drug Development
  • World
  • India
  • China
  • Health Provider Density
  • Hospital Discharge

The TT##CL consortium announced that it has been aw arded EUR ## million to develop an oral treatment, D##, against one of the most neglected tropical diseases, cutaneous leishmaniasis.

  • Autoimmune Disease
  • United States
  • Medical Technology Density
  • Rural Population

In October 2014, Novartis has signed an exclusive worldwide licensing agreement with the Global Alliance for TB Drug Development (TB Alliance) for compounds to fight tuberculosis (TB) that have been discovered at the Novartis Institutes for Tropical Diseases (NITD).

  • Tuberculosis
  • Drug Development
  • World
  • South Africa
  • India
  • Sichuan
  • Chongqing Municipality
  • Guangdong
  • Tibet
  • Drug Approval
  • Stem Cell Transplantation

In June 2013, Aix-Marseille Universite filed a patent EP##.## titled "A new chemical family to treat tropical diseases induced by Dengue virus and other Flaviviruses".

  • Infectious Disease
  • World
  • Japan
  • Hawaii
  • South Africa
  • Drug Approval
  • Health Provider Density

In June 2013, Aix-Marseille Universite filed a patent EP##.## titled "A new chemical family to treat tropical diseases induced by Dengue virus and other Flaviviruses".

  • Infectious Disease
  • United States
  • Japan
  • Drug Approval
  • Pharmaceutical Registrations

In September 2010, Themis Bioscience formed a joint R&D program collaboration with Institut Pasteur to fight tropical infectious diseases including chickungunya.

  • Infectious Disease
  • World
  • India
  • Hawaii
  • Drug Approval
  • Surgical Procedures Performed

The company stated that ATI-## is eligible for a Neglected Tropical Disease Priority Review Voucher if first approved by the U.S. Food and Drug Administration (FDA) for the treatment of cryptococcal meningitis

  • Infectious Disease
  • Drug Development
  • World
  • South Africa
  • Toyama Prefecture
  • Shaanxi
  • Drug Approval
  • Pharmaceutical Registrations

It had been concluded in the meeting that atopic dermatitis is the most prevalent chronic inflammator y skin disease in SSA. Besides neglected tropical diseases (NTDs) with a dermatological presentation, AD requires closer attention from the WHO and national Departments of Health.

  • Dermatological Condition
  • Pharmaceutical
  • United States
  • Europe
  • APAC
  • Africa
  • Health Expenditure
  • Drug Approval

For instance, the Italian Society of Infectious and Tropical Diseases (SIMIT) represented physicians, scientists and other healthcare professionals that specialize in the infectious diseases with an aim to improve the diagnosis, treatment and prevention of these diseases.

  • Infectious Disease
  • APAC
  • World
  • United States
  • Europe
  • North America
  • Drug Approval
  • Health Expenditure

The company stated that ATI-## is eligible for a Neglected Tropical Disease Priority Review Voucher if first approved by the U.S. Food and Drug Administration (FDA) for the treatment of cryptococcal meningitis

  • Meningococcal
  • World
  • Toyama Prefecture
  • Chongqing Municipality
  • HIV AIDS Prevalence
  • Diagnostic Imaging Density

The company stated that ATI-## is eligible for a Neglected Tropical Disease Priority Review Voucher if first approved by the U.S. Food and Drug Administration (FDA) for the treatment of cryptococcal meningitis

  • Infectious Disease
  • Toyama Prefecture
  • South Africa
  • Shaanxi
  • Indiana
  • Drug Approval
  • HIV AIDS Prevalence

The Company has slowed down its development programs in Neglected Tropical Diseases (NTDs) caused by viruses such as Dengue viruses and Rabies during the economic crisis of 2009 in order to conserve resources.

  • Infectious Disease
  • World
  • China
  • South Africa
  • Drug Approval
  • Infectious Disease Mortality

The Company has slow ed dow n its development programs in Neglected Tropical Diseases (NTDs) caused by viruses such as Dengue viruses and Rabies during the economic crisis of 2009 in order to conserve r esources.

  • Infectious Disease
  • World
  • China
  • Drug Approval
  • Biologics Penetration Rate

Dr. Rogelio López-Vélez, head of the National Referral Unit for Tropical Diseases of the Ramón y Cajal University Hospital in Madrid, Spain, said, "The positive opinion of the CHMP for the approval of this single-dose oral cholera vaccine is excellent news for all those who are dedicated to the practice of Travel Medicine.

  • Infectious Disease
  • Pharmaceutical
  • World
  • United States
  • Drug Approval
  • Infectious Disease Prevalence

Dr. Rogelio López-Vélez, head of the National Referral Unit for Tropical Diseases of the Ramón y Cajal University Hospital in Madrid, Spain, said, "The positive opinion of the CHMP for the approval of this single-dose oral cholera vaccine is excellent news for all those who are dedicated to the practice of Travel Medicine.

  • Infectious Disease
  • World
  • United States
  • Drug Approval
  • Infectious Disease Prevalence

Impavido® (miltefosine) is the first and only oral treatment approved by the FDA for visceral, mucosal and cutaneous leishmaniasis (a rare tropical parasitic disease).

  • Infectious Disease
  • Therapy
  • World
  • United States
  • Mortality Rate
  • Cash Transactions

According to the Indian Council Of Medical Research, India is the fourth largest spender and is responsible for the lion's share of public funding among low and middle-income countries (LMICs) when it comes to research and development on tropical diseases.

  • Pathology
  • Infectious Disease
  • World
  • APAC
  • North America
  • Europe
  • Health Expenditure
  • Mortality Rate

Vault Pharma is in preclinical development stages for a therapeutic vaccine for chlamydiarelated pelvic inflammatory disease, a major cause of pain and infertility in young women; and trachoma, a neglected tropical disease that is the leading cause for blindness in developing countries.

  • Cancer
  • Sexually Transmitted Disease
  • Indiana
  • Pharmaceutical Registrations
  • Cause-Specific Mortality Rate

Dr. Hanna has been a leading scientist and educator in the fields of pathology and microbiology, having completed a ##-year career at NYU Langone Medical Center, in addition to his ownership in the Village Lab, a NYC tropical diseases laboratory.

  • Infectious Disease
  • Immunodiagnostics
  • United States
  • World
  • North America
  • Medical Technology Density
  • Direct Sales